Sandra Cottrell is Head of the Therapeutic Area, Regulatory Affairs, at Novo Nordisk Inc.  Prior to joining Novo Nordisk, she served as Vice President at B&H Consulting Services, Inc., assisting companies in defining global regulatory strategic objectives.  She was Global Vice President of Regulatory Affairs for INO Therapeutics L.L.C., and ahe has over 25 years experience within Johnson & Johnson.  With over 30 years working across various therapeutic areas, she has an in-depth knowledge of drug development, with experience in large, mid-sized, and small pharmaceutical companies.  Beginning her career as a bench chemist, Dr. Cottrell has experience in project management and global development teams.  She has prepared CMC and scientific communication documents, provided strategic leadership for global submissions, served as a health authority liaison, and, as Regulatory Vice President, established company GCP compliance and pharmacovigilance processes.  She received her bachelor’s and master’s degrees in Chemistry and doctorate in Pharmaceutics from Temple University.

Return to Faculty Home